668276-28-6

Basic information

• Product Name: 1,5-Naphthyridine,2-(bromomethyl)-(9CI)
• Synonyms: 1,5-Naphthyridine,2-(bromomethyl)-(9CI);2-(bromomethyl)-1,5-naphthyridine
• CAS NO: 668276-28-6
• Molecular Formula: C₉H₇BrN₂
• Molecular Weight: 223.06928
• Product Categories: QUINOXALINE
• Mol File: 668276-28-6.mol

Chemical Properties

• Boiling Point: 313.0±27.0 °C(Predicted)
• Appearance: /
• Density: 1.599±0.06 g/cm3(Predicted)
• PKA: 2.03±0.10(Predicted)
• CAS DataBase Reference: 1,5-Naphthyridine,2-(bromomethyl)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1,5-Naphthyridine,2-(bromomethyl)-(9CI)(668276-28-6)
• EPA Substance Registry System: 1,5-Naphthyridine,2-(bromomethyl)-(9CI)(668276-28-6)

Safety Data

• Hazardous Substances Data: 668276-28-6(Hazardous Substances Data)

Usage

Structure

Naphthyridine derivative with a bromomethyl functional group

Applications

a. Organic synthesis
b. Building block for pharmaceuticals, agrochemicals, and functional materials
c. Medicinal chemistry for drug development

Potential health hazards

Brominated organic compound, handle with caution

Safety

Proper handling and safety measures required to minimize health risks

Relevant articles and documents

BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF GLYTL MEDIATED DISORDERS

The present invention relates to benzoxazinone derivatives, processes for their preparation, pharmaceutical compositions and medicaments containing them and to their use in treating disorders mediated by GlyT1, including neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder.

8-[3-Amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical composition

The present invention relates to substituted xanthines of general formula wherein R1 and R2 are defined as in the claims, the tautomers, the stereoisomers, the mixtures thereof, and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).

NOVEL 8-(PIPERAZINE-1-YL)- AND 8-([1,4]DIAZEPAN-1-YL)-XANTHINE, THE PRODUCTION AND USE THEREOF IN THE FROM OF A DRUG

The invention relates to a substituted XANTHINE of formula (I), wherein R1 to R3 and n are such as defined in claims from 1 to 8 and tautomers, enantiomers, diastereomers, mixtures, prodrugs and the salts thereof, said substances exhibiting valuable pharmacological properties, in particular an inhibition on the activity of dipeptidylpeptidasa-IV enzyme (DPP-IV).

8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PRODUCTION THEREOF, AND THE USE OF THE SAME AS MEDICAMENTS

The invention relates to substituted xanthines of general formula (I) wherein R1 and R2 have the designations cited in patent claims 1 to 3. The invention also relates to the tautomers, stereoisomers, mixtures and salts of said xanthines, exhibiting valuable pharmacological properties, especially an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).